alaproclate has been researched along with Dyslipidemias in 1 studies
alaproclate: specific 5-hydroxytryptamine uptake inhibitors; RN given refers to (DL)-isomer
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vilahur, G | 1 |
| Casani, L | 1 |
| Mendieta, G | 1 |
| Lamuela-Raventos, RM | 1 |
| Estruch, R | 1 |
| Badimon, L | 1 |
1 other study available for alaproclate and Dyslipidemias
| Article | Year |
|---|---|
Beer elicits vasculoprotective effects through Akt/eNOS activation.
Topics: Acetylcholine; Alanine; Animals; Beer; Cholesterol; Coronary Artery Disease; Coronary Vessels; Diet, | 2014 |